631 related articles for article (PubMed ID: 28110817)
1. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase.
Wei M; Chai WM; Wang R; Yang Q; Deng Z; Peng Y
Bioorg Med Chem; 2017 Feb; 25(4):1303-1308. PubMed ID: 28110817
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.
Azimi F; Azizian H; Najafi M; Hassanzadeh F; Sadeghi-Aliabadi H; Ghasemi JB; Ali Faramarzi M; Mojtabavi S; Larijani B; Saghaei L; Mahdavi M
Bioorg Chem; 2021 Sep; 114():105127. PubMed ID: 34246971
[TBL] [Abstract][Full Text] [Related]
4. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.
Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI
Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
12. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
15. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and α-glucosidase inhibition activity of dihydroxy pyrrolidines.
Kasturi S; Surarapu S; Uppalanchi S; Anireddy JS; Dwivedi S; Anantaraju HS; Perumal Y; Sigalapalli DK; Babu BN; Ethiraj KS
Bioorg Med Chem Lett; 2017 Jun; 27(12):2818-2823. PubMed ID: 28495082
[TBL] [Abstract][Full Text] [Related]
18. Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.
Garlapati R; Pottabathini N; Gurram V; Kasani KS; Gundla R; Thulluri C; Machiraju PK; Chaudhary AB; Addepally U; Dayam R; Chunduri VR; Patro B
Org Biomol Chem; 2013 Aug; 11(29):4778-91. PubMed ID: 23778751
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
